FDA Inspection
Matson, Mark A., MD, Clinical Investigator, Prism ResearchMatson, Mark A., MD, Clinical Investigator, Prism Research – FDA Inspection, Nov 15, 2017
Record Details
This FDA Inspection record concerns Matson, Mark A., MD, Clinical Investigator, Prism Research, with an inspection on November 15, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 15, 2017
- Product Type
- Drugs
View Company Profile
ID · e6b7f2a2-a5bf-4535-b131-52dcd80ae28b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1031352
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 50.25(a)(2)Reasonably foreseeable risks or discomforts
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Matson, Mark A., MD, Clinical Investigator, Prism Research
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 18, 2017 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Matson, Mark A., MD, Clinical Investigator, Prism Research
- FDA Inspection 999120 - 2017-01-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.